Records containing: Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-03-10A Phase I Trial Of Sequential Administration Of Triapine (3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone) Followed By Fludarabine In Adults With Relapsed And Refractory Leukemias And Myelodysplasias
-
CLINICAL_TRIALS study record update · 2010-03-10Phase I Clinical-Labratory Study of the Histone Deacetylase (HDA) Inhibitor MS-275 in Adults With Refractory and Relapsed Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2010-02-24The Unrelated Donor Marrow Transplantation Trial
-
CLINICAL_TRIALS study record update · 2010-01-26Phase I Study of 12-O-tetradecanoylphorbol-13-acetate (TPA) in Patients With Refractory Hematologic Malignancies/Bone Marrow Disorders
-
CLINICAL_TRIALS study record update · 2010-01-15A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-12-31Transplantation of Umbilical Cord Blood for Myeloid Leukemia Patients Not in CR With Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloablative Preparative Regimen and UCB NK Cells
-
CLINICAL_TRIALS study record update · 2009-09-03A Phase I/II Study of Double Unit Umbilical Cord Blood (UCB) Transplantation Utilizing Graft Administration Via Intra-Bone Marrow Injection (Companion Protocol to MT2000-25)
-
CLINICAL_TRIALS study record update · 2009-07-08Molecular and Functional Characterisation of Bone Marrow Function in Normal Subjects, Myelodysplastic Syndromes (MDS) and Secondary Disorders of Heamatopoiesis
-
CLINICAL_TRIALS study record update · 2009-05-12Phase II Multicenter Study of Amifostine in Patients With Myelodysplastic Syndromes at Relatively Low Risk of Developing Acute Leukemia
-
CLINICAL_TRIALS study record update · 2009-03-12A Randomised Controlled Trial of Prolonged Treatment With Darbepoetin Alpha With or Without Recombinant Human Granulocyte Colony Stimulating Factor (G-CSF) Versus Best Supportive Care in Patients With Low-Risk Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2009-02-09A Randomized Phase III Study to Assess Intensification of the Conditioning Regimen for Allogenic Stem Cell Transplantation (ALLO-SCT) for Leukemia or Myelodysplastic Syndrome With a High Risk of Relapse
-
CLINICAL_TRIALS study record update · 2008-06-03Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2008-03-04HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2008-03-04A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2008-03-04A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2007-05-17A Phase II Study of Darbepoetin Alpha in Myelodysplastic Syndromes (MSD)
-
CLINICAL_TRIALS study record update · 2007-04-23Adjuvant Cellular Immunotherapy for High-Risk Hematologic Malignancy After Allogeneic Stem Cell Transplantation Using Low Intensity Conditioning
-
CLINICAL_TRIALS study record update · 2007-04-04Thalidomide for the Treatment of Cytopenias of Patients With Low Risk Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2007-03-12Phase II Study of the Efficacy and Safety of Lenalidomide in Adult Subjects With Intermediate-2-or Higt Risk Myelodysplastic Syndrome(MDS) Associated With a Deletion (DEL) 5q [31]
-
CLINICAL_TRIALS study record update · 2006-06-26Treatment of Hematologic Malignancies With High-Dose Chemo-Radiotherapy Followed by Single-Unit or Double-Unit Cord Blood Transplantation: A Phase II Study